Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Alibaba Health Information Technology Ltd?

Accepted Answer

Según el último estado financiero (Form-10K), Alibaba Health Information Technology Ltd tiene un total de activos de $21,178, una ganancia neta profit de $1,432

Question 2

¿Cuáles son los ratios financieros clave para ALBBY?

Accepted Answer

El ratio corriente de Alibaba Health Information Technology Ltd es 4.35, el margen neto es 4.68, las ventas por acción son $1.89.

Question 3

¿Cómo se desglosan los ingresos de Alibaba Health Information Technology Ltd por segmento o geografía?

Accepted Answer

Alibaba Health Information Technology Ltd largest revenue segment is Pharmaceutical Direct Sales, at a revenue of 28,204,711,439 in the most earnings release.For geography, China is the primary market for Alibaba Health Information Technology Ltd, at a revenue of 33,034,838,530.

Question 4

¿Es rentable Alibaba Health Information Technology Ltd?

Accepted Answer

yes, según los últimos estados financieros, Alibaba Health Information Technology Ltd tiene una ganancia neta profit de $1,432

Question 5

¿Tiene Alibaba Health Information Technology Ltd alguna deuda?

Accepted Answer

yes, Alibaba Health Information Technology Ltd tiene una deuda de 4,866

Question 6

¿Cuántas acciones en circulación tiene Alibaba Health Information Technology Ltd?

Accepted Answer

Alibaba Health Information Technology Ltd tiene un total de acciones en circulación de 16,076.36

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	30,598	30,598	27,026	26,763	20,577	15,518
Revenue Growth (YoY)	13%	13%	1%	30%	33%	62%
Cost of Revenue	23,166	23,166	21,131	21,061	16,469	11,901
Gross Profit	7,432	7,432	5,895	5,701	4,107	3,617
Selling, General & Admin	2,683	2,672	2,136	2,161	2,376	1,529
Research & Development	720	720	705	677	728	423
Operating Expenses	6,087	5,834	5,169	5,670	5,106	3,567
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	1,559	1,559	939	550	-252	401
Income Tax Expense	127	127	56	14	13	58
Net Income	1,432	1,432	883	535	-265	348
Net Income Growth	62%	62%	65%	-302%	-176%	-5,900%
Shares Outstanding (Diluted)	16,175.08	16,135.8	14,090.69	13,541.57	13,482.63	13,326.52
Shares Change (YoY)	11%	15%	4%	0%	1%	12%
EPS (Diluted)	0.08	0.08	0.06	0.03	-0.01	0.02
EPS Growth	41%	42%	57.99%	-301%	-175%	-4,467%
Free Cash Flow	1,376	1,376	1,057	249	409	991
Free Cash Flow Per Share	0.08	0.08	0.07	0.01	0.03	0.07
Gross Margin	24.28%	24.28%	21.81%	21.3%	19.95%	23.3%
Operating Margin	4.39%	5.21%	2.68%	0.11%	-4.85%	0.32%
Profit Margin	4.68%	4.68%	3.26%	1.99%	-1.28%	2.24%
Free Cash Flow Margin	4.49%	4.49%	3.91%	0.93%	1.98%	6.38%
EBITDA	1,401	1,654	778	94	-938	83
EBITDA Margin	4.57%	5.4%	2.87%	0.35%	-4.55%	0.53%
D&A For EBITDA	57	57	53	63	60	33
EBIT	1,344	1,597	725	31	-998	50
EBIT Margin	4.39%	5.21%	2.68%	0.11%	-4.85%	0.32%
Effective Tax Rate	8.14%	8.14%	5.96%	2.54%	-5.15%	14.46%

Alibaba Health Information Technology Ltd (ALBBY) Price

ALBBY Stock Price Chart

ALBBY Income

Follow-Up Questions